Clinical Trial Update: Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination-2nd Trial [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetics study comparing a fixed-dose combination of clopidogrel and aspirin to the separate components has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Aspirin (Aspirin)
• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Coronary Artery Disease | Phase 1 | Status: COMPLETED